GlassScriptPhysician profile
Emmanuel J Esaka
NPI 1356597231
$2,614.00
in general payments reported to CMS, 2019-2025
26 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2020: $435 · 2021: $642 · 2022: $351 · 2023: $309 · 2024: $205 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590 · Education: $85.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.87 |
| Education | $85.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $407.27 | 2019-2021 | |
| Astellas Pharma US INC | $364.21 | 2022-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $356.43 | 2019-2024 | Slynd, Nuvessa |
| Abbvie INC. | $282.19 | 2020-2023 | |
| Mylan Pharmaceuticals INC. | $193.84 | 2019-2022 | |
| Evofem Biosciences, INC. | $176.95 | 2020-2023 | Phexxi |
| Avion Pharmaceuticals | $170.82 | 2019-2022 | |
| Agile Therapeutics, INC. | $129.20 | 2021-2023 | Twirla |
| Organon LLC | $68.47 | 2024 | |
| Shield Therapeutics INC | $57.14 | 2023-2025 | Accrufer |
| Mission Pharmacal Company | $55.17 | 2019-2020 | |
| Myovant Sciences INC. | $50.63 | 2021 | |
| Therapeuticsmd, INC. | $41.24 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.94 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $32.90 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $24.59 | 2024 | Tymlos |
| Covidien LP | $22.60 | 2019 | |
| Aspira Women'S Health INC | $21.05 | 2020 | |
| Coopersurgical, INC. | $20.08 | 2024 | Paragard T 380a |
| Biohaven Pharmaceutical Holding Company LTD. | $19.92 | 2022 | |
| Exact Sciences Corporation | $17.99 | 2025 | The Cologuard Plus Collection Kit |
| Millicent US INC | $17.35 | 2025 | Intrarosa, Femlyv |
| Hologic Sales and Service, LLC | $15.81 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $11.96 | 2020 | |
| Allergan, INC. | $11.18 | 2019 | |
| Scynexis, INC. | $11.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emmanuel Esaka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.